Boston Scientific’s (NYSE:BSX) Endoscopy business refers to the company’s devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions. We have created an interactive dashboard analysis ~ How Important Is Endoscopy For Boston Scientific’s Stock? The overall endoscopy devices market has also seen steady growth in the past years, aiding Boston Scientific’s sales growth. Global endoscopy devices market is estimated to grow at a CAGR of 6% to $38.5 billion by 2024. What’s The Contribution of Endoscopy To Boston Scientific’s Share Price?

Source: Forbes April 04, 2019 14:15 UTC